How horizon scanning can help predict the future for EU’s Alzheimer’s disease market
Aduhelm’s US launch has prompted a new look into what is in store for the Alzheimer’s disease market over the coming years.
By
Aduhelm’s US launch has prompted a new look into what is in store for the Alzheimer’s disease market over the coming years.
By Eoin RyanForeign investment in Ireland’s pharmaceutical sector has gone from strength to strength in 2019. With major new multi-billion-dollar investment…
By Eoin RyanThe recent publication of Norway’s Statistik Sentralbyrå (SSB) annual healthcare and pharmaceutical expenditure statistics confirms the accuracy of IHS…
By Eoin RyanItaly’s public procurement agency, CONSIP, has this month updated the list of pharmaceutical products under a 2017-21 tender with…
By Eoin RyanThe pharmaceutical sector in Norway has responded to recent criticism levelled at the industry by healthcare authorities related to…
By Eoin RyanThe UK’s future eligibility to participate in the Unified Patent Court (UPC) and unitary patent system rests on a…
By Eoin RyanLast month’s proposals by the European Commission for the creation of a single, mandatory system for clinical health technology…
By Eoin RyanItaly’s failure to win the EMA relocation vote has been likened to losing on penalties in the World Cup.…
By Eoin RyanIn late March the Danish Institute for Local and Regional Government Research (KORA) published research mapping similarities and differences…
By Eoin Ryan